|
Cellerix Cellerix is a biopharmaceutical company focused on developing a cell therapy platform capable of delivering off-the-shelf products to treat inflammatory and autoimmune diseases, using primarily expanded stem cells derived from adipose tissue (eASCs). Cellerix-Tigenix project started as a basic R&D project having become, under Genetrix's managment, a quoted international company in the Belgium stock exchange market (EURONEXT). |
 |